← Open Payments lookup

CHARMAINE CORONADO: Open Payments

NPI 1144860057 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$687 in 31 payments from 9 companies in 2025. Trend: 2023 $422 · 2024 $600 · 2025 $687

Food & beverage: $687
CompanyPaymentsAmount
GlaxoSmithKline, LLC.10$237
AstraZeneca Pharmaceuticals LP7$152
Amgen Inc.4$92
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$70
PFIZER INC.2$44
Novo Nordisk Inc2$36
Boston Scientific Corporation1$21
ABBVIE INC.1$19
Phadia US Inc.1$17

Products named: TRELEGY ELLIPTA, FARXIGA, OTEZLA, CAPLYTA, AIRSUPRA, ELIQUIS, Rybelsus, TheraSphere Administration Set.

Industry payments across NV — which companies pay providers there.